Blockchain Registration Transaction Record
GeoVax to Present at Emerging Growth Conference Following BARDA Contract Termination
GeoVax Labs, Inc. to discuss BARDA contract termination and latest developments at the Emerging Growth Conference. Learn about the Company's innovative vaccine programs and potential impact on stakeholders' decisions.

This news highlights GeoVax's strategic response to the termination of a key contract and offers stakeholders an opportunity to engage directly with the Company's leadership. Investors can gain valuable insights into GeoVax's pipeline of immunotherapies and vaccines, particularly the advanced COVID-19 vaccine program, potentially shaping investment decisions and future collaborations.
Blockchain | Details |
---|---|
Contract Address | 0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71 |
Transaction ID | 0xfc564f75241c2187853835702f52126e125bc5127fca39a1ae8aee2715bcfbf4 |
Account | 0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20 |
Chain | polygon-main |
NewsRamp Digital Fingerprint | glowzCV1-378fedc2ac01e8e9d42f7335028d01da |